107 related articles for article (PubMed ID: 36229929)
1. RNA-sequencing for transcriptional profiling of whole blood in early stage and metastatic pancreatic cancer patients.
Kalantari S; Kazemi B; Roudi R; Zali H; D'Angelo A; Mohamadkhani A; Madjd Z; Pourshams A
Cell Biol Int; 2023 Jan; 47(1):238-249. PubMed ID: 36229929
[TBL] [Abstract][Full Text] [Related]
2. An Integrated Microarray Analysis Reveals Significant Diagnostic and Prognostic Biomarkers in Pancreatic Cancer.
Yang ZQ; Liu YJ; Zhou XL
Med Sci Monit; 2020 Apr; 26():e921769. PubMed ID: 32235821
[TBL] [Abstract][Full Text] [Related]
3. SOCS3 methylation in synergy with Reg3A overexpression promotes cell growth in pancreatic cancer.
Wang J; Zhou H; Han Y; Liu X; Wang M; Wang X; Yin G; Li X; Xiang M
J Mol Med (Berl); 2014 Dec; 92(12):1257-69. PubMed ID: 24996521
[TBL] [Abstract][Full Text] [Related]
4. Spatiotemporal proteomic analyses during pancreas cancer progression identifies serine/threonine stress kinase 4 (STK4) as a novel candidate biomarker for early stage disease.
Mirus JE; Zhang Y; Hollingsworth MA; Solan JL; Lampe PD; Hingorani SR
Mol Cell Proteomics; 2014 Dec; 13(12):3484-96. PubMed ID: 25225358
[TBL] [Abstract][Full Text] [Related]
5. Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer.
Liu R; Chen X; Du Y; Yao W; Shen L; Wang C; Hu Z; Zhuang R; Ning G; Zhang C; Yuan Y; Li Z; Zen K; Ba Y; Zhang CY
Clin Chem; 2012 Mar; 58(3):610-8. PubMed ID: 22194634
[TBL] [Abstract][Full Text] [Related]
6. The microRNA-218 and ROBO-1 signaling axis correlates with the lymphatic metastasis of pancreatic cancer.
He H; Di Y; Liang M; Yang F; Yao L; Hao S; Li J; Jiang Y; Jin C; Fu D
Oncol Rep; 2013 Aug; 30(2):651-8. PubMed ID: 23733161
[TBL] [Abstract][Full Text] [Related]
7. A 4-gene-based hypoxia signature is associated with tumor immune microenvironment and predicts the prognosis of pancreatic cancer patients.
Ding J; He X; Cheng X; Cao G; Chen B; Chen S; Xiong M
World J Surg Oncol; 2021 Apr; 19(1):123. PubMed ID: 33865399
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic ADAM28 induces gemcitabine resistance and predicts a poor prognosis in pancreatic cancer.
Wei L; Wen JY; Chen J; Ma XK; Wu DH; Chen ZH; Huang JL
World J Gastroenterol; 2019 Oct; 25(37):5590-5603. PubMed ID: 31602160
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiles in primary pancreatic tumors and metastatic lesions of Ela-c-myc transgenic mice.
Thakur A; Bollig A; Wu J; Liao DJ
Mol Cancer; 2008 Jan; 7():11. PubMed ID: 18218118
[TBL] [Abstract][Full Text] [Related]
10. The identification of liver metastasis- and prognosis-associated genes in pancreatic ductal adenocarcinoma.
Luan H; He Y; Zhang T; Su Y; Zhou L
BMC Cancer; 2022 Apr; 22(1):463. PubMed ID: 35477379
[TBL] [Abstract][Full Text] [Related]
11. Identification of hub genes with diagnostic values in pancreatic cancer by bioinformatics analyses and supervised learning methods.
Li C; Zeng X; Yu H; Gu Y; Zhang W
World J Surg Oncol; 2018 Nov; 16(1):223. PubMed ID: 30428899
[TBL] [Abstract][Full Text] [Related]
12. A 6‑gene risk score system constructed for predicting the clinical prognosis of pancreatic adenocarcinoma patients.
Liu Y; Zhu D; Xing H; Hou Y; Sun Y
Oncol Rep; 2019 Mar; 41(3):1521-1530. PubMed ID: 30747226
[TBL] [Abstract][Full Text] [Related]
13. A competing endogenous RNA network identifies novel mRNA, miRNA and lncRNA markers for the prognosis of diabetic pancreatic cancer.
Yao K; Wang Q; Jia J; Zhao H
Tumour Biol; 2017 Jun; 39(6):1010428317707882. PubMed ID: 28639886
[TBL] [Abstract][Full Text] [Related]
14. Altered profile of serum microRNAs in pancreatic cancer-associated new-onset diabetes mellitus.
Dai X; Pang W; Zhou Y; Yao W; Xia L; Wang C; Chen X; Zen K; Zhang CY; Yuan Y
J Diabetes; 2016 May; 8(3):422-33. PubMed ID: 25991015
[TBL] [Abstract][Full Text] [Related]
15. Screening and Validation of Independent Predictors of Poor Survival in Pancreatic Cancer.
Liu S; Cai Y; Changyong E; Sheng J; Zhang X
Pathol Oncol Res; 2021; 27():1609868. PubMed ID: 34321959
[TBL] [Abstract][Full Text] [Related]
16. A Four Autophagy-Related Gene-Based Prognostic Signature for Pancreatic Cancer.
Zhou Q; Chen X; Chen Q; Liu H; Hao L
Crit Rev Eukaryot Gene Expr; 2021; 31(4):89-100. PubMed ID: 34587439
[TBL] [Abstract][Full Text] [Related]
17. Combining bioinformatics techniques to explore the molecular mechanisms involved in pancreatic cancer metastasis and prognosis.
Xu JS; Liao KL; Wang X; He J; Wang XZ
J Cell Mol Med; 2020 Dec; 24(24):14128-14138. PubMed ID: 33164330
[TBL] [Abstract][Full Text] [Related]
18. Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study.
Huang L; Jansen L; Balavarca Y; Babaei M; van der Geest L; Lemmens V; Van Eycken L; De Schutter H; Johannesen TB; Primic-Žakelj M; Zadnik V; Besselink MG; Schrotz-King P; Brenner H
BMC Med; 2018 Aug; 16(1):125. PubMed ID: 30126408
[TBL] [Abstract][Full Text] [Related]
19. Increased levels of circulating circular RNA (hsa_circ_0013587) may serve as a novel biomarker for pancreatic cancer.
Xu K; Qiu Z; Xu L; Qiu X; Hong L; Wang J
Biomark Med; 2021 Aug; 15(12):977-985. PubMed ID: 34289738
[No Abstract] [Full Text] [Related]
20. Identify potential clinical significance of long noncoding RNA forkhead box P4 antisense RNA 1 in patients with early stage pancreatic ductal adenocarcinoma.
Liu XG; Xu H; Chen M; Tan XY; Chen XF; Yang YG; Lin MZ; Liu GH; Liang XL; Qian YB; Yuan GJ; Chen MQ; Li WT; Miao HL; Li MY; Liao XW; Dai W; Chen NP
Cancer Med; 2020 Mar; 9(6):2062-2076. PubMed ID: 31991068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
